Skip to main content

Table 6 Summary of LIPID genetic study and previous studies assessing GRS in prediction of secondary cardiovascular risk in patients with documented cardiovascular disease and post-ACS

From: Common genetic variants do not predict recurrent events in coronary heart disease patients

Author

References

Patients

n

Duration of follow-up (years)

CV events

Fatal CV events

Type of GRS

Independent association with CV events

Patel et al. 2012

[16]

CAD on angiography

2597

2.5

358

257

11 SNPs

No independent association

Weijmans et al. 2015

[17]

Symptomatic vascular disease

5742

6.5

933

N/R

30 SNPs

No independent association

Labos et al. 2015

[18]

ACS

3503

1

389

N/R

30 SNPs

No independent association

Vaara et al. 2015

[19]

ACS with coronary angiography

2090

5.5

263

N/R

47 SNPs

153 SNPs

GRS 47. Adj HR 1.17; 95% CI, 1.01–1.36 p = 0.037. No improvement in C-statistic

GRS 153. No association

Mega et al. 2015

[8]

Recent ACS (CARE)

2878

4.94

330

N/R

27 SNPs

HR 1.14 (0.98–1.32) per SD of GRS p = 0.081

Mega et al. 2015

[8]

Recent ACS (PROVE-IT)

1999

2.03

22

N/R

27 SNPs

HR 1.14 (0.95–1.36) per SD of GRS p = 0.15

Christiansen et al. 2017

[20]

High-risk stable CHD

879

2.8

N/R

N/R

45 SNPs

Adj. HR 1.50 (95% CI 1.00–2.25) for all CV events including revascularisation. Risks of CV death and all-cause death unaffected

Wirtwein et al. 2017

[21]

CHD on angiography

1345

8.6

882

114

19 SNPs

Inconsistent

Pereira et al. 2017

[22]

CHD Southern Europe

1464

4.9

N/R

107

32 SNPs

No independent association

Jiang et al. 2020

[23]

Chinese patients Recent ACS

1667

2

N/R

N/R

79 SNPs

HR 1.33 (1.10–1.61) P = 0.003 per SD of GRS; slight increase in discrimination after adjustment for clinical factors

Current study

 

CHD, distant ACS

4932

 > 10

554

(2 years)

898

(10 years)

27 SNPs (same as Mega et al.)

No independent association

No improvement in NRI or C-statistic

  1. ACS acute coronary syndromes, AMI acute myocardial infarction, CAD coronary artery disease, CHD coronary heart disease, CVD cardiovascular disease, CARE Cholesterol and Coronary Events trial, PROVE-IT Pravastatin or Atorvastatin Evaluation and Infection Therapy, HR hazard ratio, GRS genetic risk score, CI confidence interval, Adj adjusted, N/R not reported